REVANCE THERAPEUTICS INC's ticker is RVNC and the CUSIP is 761330109. A total of 191 filers reported holding REVANCE THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.60 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $21,725,407 | -56.1% | 1,894,107 | -3.2% | 0.00% | -50.0% |
| Q2 2023 | $49,504,209 | -58.4% | 1,955,915 | -47.0% | 0.00% | -20.0% |
| Q1 2023 | $118,869,846 | +255.9% | 3,690,464 | +104.0% | 0.01% | +66.7% |
| Q4 2022 | $33,398,847 | -29.3% | 1,809,255 | +3.4% | 0.00% | -40.0% |
| Q3 2022 | $47,223,000 | +181.4% | 1,748,990 | +44.0% | 0.01% | +150.0% |
| Q2 2022 | $16,782,000 | -30.1% | 1,214,318 | -1.4% | 0.00% | 0.0% |
| Q1 2022 | $24,021,000 | +24.7% | 1,231,830 | +4.4% | 0.00% | +100.0% |
| Q4 2021 | $19,261,000 | -74.3% | 1,180,185 | -56.1% | 0.00% | -83.3% |
| Q3 2021 | $74,976,000 | -6.1% | 2,691,156 | -0.2% | 0.01% | 0.0% |
| Q2 2021 | $79,889,000 | +2.9% | 2,695,300 | -2.9% | 0.01% | -14.3% |
| Q1 2021 | $77,609,000 | -4.0% | 2,776,700 | -2.6% | 0.01% | 0.0% |
| Q4 2020 | $80,826,000 | +168287.5% | 2,852,000 | +150005.3% | 0.01% | – |
| Q3 2020 | $48,000 | -74.2% | 1,900 | -75.0% | 0.00% | – |
| Q2 2020 | $186,000 | +66.1% | 7,600 | 0.0% | 0.00% | – |
| Q1 2020 | $112,000 | -8.9% | 7,600 | -0.3% | 0.00% | – |
| Q4 2019 | $123,000 | – | 7,625 | +30400.0% | 0.00% | – |
| Q3 2019 | $0 | -100.0% | 25 | -99.9% | 0.00% | – |
| Q2 2019 | $459,000 | -54.7% | 35,425 | -44.9% | 0.00% | – |
| Q1 2019 | $1,013,000 | -42.0% | 64,325 | -25.9% | 0.00% | – |
| Q4 2018 | $1,748,000 | -79.9% | 86,826 | -75.2% | 0.00% | -100.0% |
| Q3 2018 | $8,699,000 | +192.9% | 350,030 | +223.5% | 0.00% | – |
| Q2 2018 | $2,970,000 | -60.7% | 108,200 | -56.0% | 0.00% | -100.0% |
| Q1 2018 | $7,566,000 | +5.0% | 245,636 | +21.8% | 0.00% | 0.0% |
| Q4 2017 | $7,207,000 | +5.0% | 201,600 | -19.1% | 0.00% | 0.0% |
| Q3 2017 | $6,865,000 | -20.2% | 249,200 | -23.5% | 0.00% | 0.0% |
| Q2 2017 | $8,604,000 | +30.5% | 325,900 | +2.8% | 0.00% | 0.0% |
| Q1 2017 | $6,592,000 | +218.5% | 316,900 | +216.9% | 0.00% | – |
| Q4 2016 | $2,070,000 | -89.1% | 100,000 | -82.0% | 0.00% | -100.0% |
| Q4 2015 | $18,979,000 | -4.7% | 555,600 | -46.0% | 0.00% | 0.0% |
| Q3 2014 | $19,906,000 | -41.7% | 1,029,800 | +2.6% | 0.00% | -40.0% |
| Q2 2014 | $34,126,000 | +257.2% | 1,003,700 | +230.9% | 0.01% | +400.0% |
| Q1 2014 | $9,554,000 | – | 303,300 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| NovaQuest Capital Management, L.L.C. | 1,558,426 | $48,000,000 | 65.50% |
| Essex Woodlands Management, Inc. | 3,842,047 | $118,335,000 | 25.90% |
| Rhenman & Partners Asset Management AB | 203,181 | $6,258,000 | 0.77% |
| EAM Global Investors LLC | 44,898 | $1,383,000 | 0.72% |
| Fosun International Ltd | 319,313 | $9,835,000 | 0.62% |
| EAM Investors, LLC | 113,096 | $3,483,000 | 0.58% |
| Perceptive Advisors | 618,957 | $19,064,000 | 0.53% |
| ArrowMark Colorado Holdings LLC | 1,735,699 | $53,460,000 | 0.53% |
| ESSEX INVESTMENT MANAGEMENT CO LLC | 111,360 | $3,430,000 | 0.45% |
| Schonfeld Strategic Advisors LLC | 83,700 | $2,578,000 | 0.19% |